spacer
home > pmps > winter 2017 > watching the east
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Watching the East

The pharmaceutical industry is one of the most competitive sectors in the EU. It is the fifth largest industrial area and accounts for a high percentage of the global pharma market. According to the European Federation of Pharmaceutical Industries and Associations, few other fields can match its contribution to generating a trade surplus, investment in R&D and the creation of skilled employment in Europe.

While a large proportion of pharmaceutical development and manufacturing takes place on the western continent, central and eastern European countries are emerging as an attractive alternative for companies wishing to outsource parts of the supply chain due to factors such as accomplished workforces and competitive pricing.

European Landscape

The pharma sector in Europe has grown exponentially over the past ten years. Businesses have had to overcome a number of challenges, like escalating costs and downward price pressure from governments coupled with the need for faster turnaround times to bring new drugs to market, as well as increased demand for products.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Anthony Sheehan joined Saneca Pharma as Chief Executive Officer in 2015. With over 25 years’ experience in the pharma industry, he has worked as Site Managing Director at Stada as well as in various senior roles within the sector. Anthony also has experience in the automotive and engineering fields. He has an MBA from the University of Limerick, Ireland.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Business Continuity Plan - Message from Protagen Protein Services (PPS)

Following the recent COVID-19 outbreak, we at Protagen Protein Services (PPS) are preparing for all eventualities. Please be assured that PPS will continue to operate as normal providing you with all of the professional support and service you have to come to expect from us. Given the gravity of the situation, and to protect our staff, clients, and communities from the spread of the virus, we have taken various measures within a scope of a Business Continuity Plan:
More info >>

White Papers

Customising the Cold Chain

World Courier

Of all the statistics emerging around the global pharmaceutical industry this year, two big numbers capture the attention of both manufacturers and their logistics partners: $248 billion, the amount the “BRIC” nations (Brazil, Russia, India and China) are poised to account for in pharmaceutical sales for by 2016; and $8 billion, the amount global pharma will spend on cold chain logistics in 2014. Why are these two numbers so noteworthy? They demonstrate that as R&D goes, so goes logistics. As products evolve to meet demands for more targeted therapies, demand for more targeted logistics solutions grows as well. And that means a need for customization for everything from clinical trial samples to finished product.
More info >>

 
Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement